Literature DB >> 7733078

Prolonged medical therapy for severe pediatric ulcerative colitis.

D M Gold1, J J Levine, T A Weinstein, B Kessler, M J Pettei.   

Abstract

OBJECTIVES: The optimal timing of surgical intervention for severe ulcerative colitis remains uncertain. Numerous reports recommend surgery within 10-14 days if clinical remission is not achieved. We undertook a study to follow the clinical course and long-term follow-up of patients with severe ulcerative colitis treated medically for longer than 14 days (n = 11).
METHODS: We performed a retrospective review of all patients admitted to the hospital with a diagnosis of severe ulcerative colitis who were treated for more than 14 days.
RESULTS: Nine percent of patients (n = 1) required surgery during their hospitalization. Ninety-one percent of patients (n = 10, mean age 8.6 yr, 7 M, 3 F) treated with medical and nutritional therapy for more than 14 days went into clinical remission. Of these, only 10% (n = 1) ultimately required surgery; 60% remain in clinical remission up to 83 months posthospitalization (mean follow-up, 49.5 months), whereas 30% suffer from mild to moderate colitis (mean follow-up, 26.3 months).
CONCLUSIONS: These results do not support the recommendation for colectomy for refractory severe ulcerative colitis if remission is not noted within 2 wk of hospitalization.

Entities:  

Mesh:

Year:  1995        PMID: 7733078

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  Predicting the need for colectomy in pediatric patients with ulcerative colitis.

Authors:  R A Falcone; L G Lewis; B W Warner
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

Review 2.  Severe ulcerative colitis: at what point should we define resistance to steroids?

Authors:  Maria Esteve; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

3.  Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.

Authors:  Boyko Kabakchiev; Dan Turner; Jeffrey Hyams; David Mack; Neal Leleiko; Wallace Crandall; James Markowitz; Anthony R Otley; Wei Xu; Pingzhao Hu; Anne M Griffiths; Mark S Silverberg
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.